A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: A potential mechanism for mast cell activation

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 6915-6921

  Gommerman, J L ^a   Oh, D Y ^a   Zhou, X ^a   Tedder, T F ^a   Maurer, M ^a   Galli, S J ^a   Carroll, M C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; CYTOKINE; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; COMPLEMENT DEFICIENCY; FLOW CYTOMETRY; MAST CELL; MODEL; MOUSE; NEUTROPHIL; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; SEPSIS;

EID: 0034671980     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.6915     Document Type: Article

References (34)

1. Mast cell modulation of neutrophll influx and bacterial clearance at sites of infection through TNF-α
2. Critical protective role of mast cells in a model of acute septic peritonitis
3. Imparted mast cell-dependent natural immunity in complement C3-deficient mice
4. The two faces of the mast cell
5. Signalling through the high-affinity IgE receptor FceRI
6. Fc receptors
7. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice
8. A dominant role for mast cell Fc receptors in the Arthus reaction
9. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection
10. Imparted mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice
11. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model
12. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors
13. Fabronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes
14. The CD19/CR2/TAPA-1 complex of B lymphocytes linking natural to acquired immunity
15. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells
16. Dependence of germinal center B cells on expression of CD21/CD35 for survival
17. The role of complement in B cell activation and tolerance
18. Linkages of innate and adaptive immunity
19. Antibody response to a T-dependent antigen requires B cell expression of complement receptors
20. Regulation of the B cell response to T-dependent antigens by classical pathway complement
21. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen Immunity
22. CD19 expression levels regulate B lymphocyte development human CD19 restores normal function in mice lacking endogenous CD19
23. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
24. Sepsis and septic shock, a review of laboratory models and a proposal
25. Mast cells can secrete VPF/VEGF and exhibit enhanced release after IgE-dependent upregulation of FcεRI expression
26. Impairment of T-cell dependent B cell responses and B-1 cell development in CD19-deficient mice
27. Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
28. Mast cells are a source of both pre-formed and immunologically inducible TNF-α/cachectin
29. CD19 as a membrane-anchored adaptor protean of B lymphocytes costimulation of lipid and protein kinases by recruitment of vav
30. Rho GTPases and the actin cytoskeleton
31. Involvement of the ras-like GTPase rab3d an RBL-2H3 mast cell exocytosis following stimulation via high affinity IgE receptors (FcεRI)
32. The C5a chemoattractant receptor mediates mucosal defense to infection
33. Release of histamane from rat mast cells by the complement peptides C3a and C5a
34. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48